A. Levitz et al. / Dyes and Pigments 105 (2014) 238e249
241
(t, J ¼ 7.2 Hz, 1 H), 7.78 (d, J ¼ 8.4 Hz, 1 H), 7.91 (s, 1 H), 8.59 (t,
44.58, 48.73, 91.17, 99.24, 110.92, 111.92, 112.55, 122.67, 124.51,
126.38, 126.79, 128.83, 131.56, 140.61, 143.39, 147.17, 148.13, 162.40,
172.75; HRMS: Calcd for C25H29N2Oþ m/z 373.2280, obsd m/z
373.2281.
J ¼ 13.2 Hz, 1 H); 13C NMR (100 MHz, MeOD-d4):
d 20.83, 26.54,
27.09, 31.01, 40.94, 48.80, 49.75, 52.49, 63.06, 102.29, 104.66,
109.98, 111.62, 120.05, 122.10, 126.21, 126.83, 128.69, 140.36, 141.15,
142.12, 142.45, 143.25, 151.23, 173.66, 176.85. HRMS: Calcd for
C
30H40N3O3Sþ m/z 522.2785, obsd m/z 522.2783.
2.2.25. 2-((1E,3E)-3-(1-Butylbenzo[cd]indol-2(1H)-ylidene)prop-1-
en-1-yl)-1,3,3-trimethyl-3H-indol-1-ium iodide (10a)
Compound 10a was synthesized by a similar procedure to 8a.
The dye was purified by column chromatography (1% methanol/
dichloromethane). This compound was obtained in 79% yield; mp
2.2.21. 2-((1E,3E)-3-(3-Butyl-1,1-dimethyl-1H-benzo[e]indol-
2(3H)-ylidene)prop-1-en-1-yl)-1,3,3-trimethyl-3H-indol-1-ium
iodide (8i)
Compound 8i was synthesized by a similar procedure to 8a. No
purification was needed. This compound was obtained in 44% yield;
128e130 ꢀC; 1H NMR (400 MHz, MeOD-d4):
d
1.04 (t, J ¼ 7.6 Hz, 3
H), 1.50e1.60 (m, 2 H), 1.85 (s, 6 H), 1.87e1.95 (m, 2 H), 3.84 (s, 3
H), 4.32 (t, J ¼ 7.6 Hz, 2 H), 6.82 (d, J ¼ 13.6 Hz, 1 H), 6.87 (d,
J ¼ 13.6 Hz, 1 H), 7.41 (t, J ¼ 7.2 Hz, 1 H), 7.39e7.54 (m, 3 H), 7.64
(d, J ¼ 7.6 Hz, 1 H), 7.68 (d, J ¼ 7.6 Hz, 2 H), 7.77 (d, J ¼ 8.4 Hz, 1
H), 7.95 (t, J ¼ 7.6 Hz, 1 H), 8.23 (d, J ¼ 8.4 Hz, 1 H), 8.38 (d,
J ¼ 7.2 Hz, 1 H), 8.91 (t, J ¼ 13.6 Hz, 1 H); 13C NMR (100 MHz,
mp 133 ꢀC; 1H NMR (400 MHz, DMSO-d6):
d
0. 96 (t, J ¼ 7.2 Hz, 3 H),
1.42e1.52 (m, 2 H), 1.74 (s, 6 H), 1.76e1.82 (m, 2 H), 1.98 (s, 6 H), 3.67
(s, 3 H), 4.26 (t, J ¼ 7.2 Hz, 2 H), 6.50 (d, J ¼ 13.6 Hz, 1 H), 6.56 (d,
J ¼ 13.6 Hz,1 H), 7.29e7.32 (m, 1 H), 7.45 (d, 2 H), 7.54 (t, J ¼ 7.6 Hz,1
H), 7.65e7.69 (m, 2 H), 7.79 (d, J ¼ 8.4 Hz, 1 H), 8.07e8.12 (m, 2 H),
8.30 (d, J ¼ 8.4 Hz, 1 H), 8.47 (t, J ¼ 13.6 Hz, 1 H); 13C NMR (100 MHz,
MeOD-d4):
d 12.83, 14.03, 19.88, 27.30, 29.27, 31.06, 43.56, 65.49,
DMSO-d6):
d 0.58, 14.31, 20.02, 27.54, 27.80, 29.95, 31.82, 44.37,
105.97, 106.89, 109.28, 111.55, 122,11, 122.52, 125.09, 126.08,
126.61, 128.67, 129.30, 129.54, 130.29, 131.16, 141.31, 141.44,
142.58, 149.23, 155.41, 175.92. HRMS: Calcd for C29H31Nþ2 m/z
407.2482, obsd m/z 407.2499.
49.26, 51.09, 102.51, 103.17, 111.86, 112.24, 122.70, 122.91, 125.56,
127.86, 128.32, 129.05, 130.38, 130.93, 131.98, 133.76, 139.96, 140.98,
143.18, 149.49, 174.56, 175.89. HRMS: Calcd for C32H37Nþ2 m/z
449.2952, obsd m/z 449.2973.
2.2.26. 1,3,3-Trimethyl-2-((1E,3E)-3-(1-(3-(trimethylammonio)
propyl)benzo[cd]indol-2(1H)-ylidene)prop-1-en-1-yl)-3H-indol-1-
ium bromide (10b)
2.2.22. 2-((1E,3E)-3-(5-Bromo-3,3-dimethyl-1-(3-
(trimethylammonio)propyl)indolin-2-ylidene)prop-1-en-1-yl)-
1,3,3-trimethyl-3H-indol-1-ium bromide (8j)
Compound 10b was synthesized by a similar procedure to 8a.
No purification was needed. This compound was obtained in 75%
Compound 8j was synthesized by a similar procedure to 8a.
No purification was needed. This compound was obtained in 77%
yield; mp 134 ꢀC; 1H NMR (400 MHz, MeOD-d4):
d 1.77 (s, 6 H),
yield; mp 226 ꢀC; 1H NMR (400 MHz, DMSO-d6):
d 1.69 (s, 6 H),
2.23e2.30 (m, 2 H), 3.10 (s, 9 H), 3.62e3.66 (m, 2 H), 4.33 (t,
J ¼ 6.4 Hz, 2 H), 7.05 (d, J ¼ 13.6 Hz, 1 H), 7.12 (d, J ¼ 12.8 Hz, 1 H),
7.42 (t, J ¼ 7.6 Hz, 1 H), 7.54 (t, J ¼ 7.6 Hz, 1 H), 7.58 (d, 7.2 Hz, 1
H), 7.64 (d, J ¼ 8.0 Hz, 1 H), 7.72 (t, J ¼ 6.8 Hz, 1 H), 7.74e7.79 (m,
2 H), 8.00 (t, J ¼ 7.6 Hz, 1 H), 8.28 (d, J ¼ 8.4 Hz, 1 H), 8.36 (d,
J ¼ 7.2 Hz, 1 H), 8.73 (t, J ¼ 13.6 Hz, 1 H); 13C NMR (100 MHz,
1.71 (s, 6 H), 2.11e2.15 (m, 2 H), 3.10 (s, 9 H), 3.59 (t, J ¼ 6.8 Hz, 2
H), 3.71 (s, 3 H), 4.08 (t, J ¼ 7.2 Hz, 2 H), 6.68 (t, J ¼ 12.4 Hz, 2 H),
7.36 (t, J ¼ 7.6 Hz, 1 H), 7.45e7.50 (m, 2 H), 7.55 (d, J ¼ 8.0 Hz, 1
H), 7.67 (t, J ¼ 7.6 Hz, 2 H), 7.93 (s, 1 H), 8.34 (t, J ¼ 13.2 Hz, 1 H);
13C NMR (100 MHz, DMSO-d6):
d 21.09, 27.54, 27.92, 32.37, 41.20,
49.16, 49.76, 53.05, 62.81, 102.58, 104.89, 112.60, 113.32, 117.50,
122.96, 126.26, 126.37, 129.14, 131.74, 141.38, 141.70, 142.98,
143.10, 150.36, 172.76, 176.08. HRMS: Calcd for C22H23N2Sþ m/z
26.6198, obsd m/z 260.62.
MeOD-d4):
d 22.57, 28.09, 32.93, 40.93, 50.30, 52.99, 63.01,
107.73, 108.47, 109.39, 113,17, 122.44, 123.06, 125.23, 126.93,
127.19, 129.22, 129.80, 130.09, 130.23, 130.64, 131.41, 141.40,
142.09, 142.96, 148.87, 154.21, 176.40. HRMS: Calcd for C31H37N32þ
m/z 225.6488, obsd m/z 225.6170.
2.2.23. 1,3,3-Trimethyl-2-((1E,3Z)-3-(3-methylbenzo[d]thiazol-
2(3H)-ylidene)prop-1-en-1-yl)-3H-indol-1-ium iodide (9a)
Compound 9a was synthesized by a similar procedure to 8a. No
purification was needed. This compound was obtained in 67% yield;
2.2.27. 2-((1E,3E)-3-(1-Butylbenzo[cd]indol-2(1H)-ylidene)prop-1-
en-1-yl)-1-methylbenzo[cd]indol-1-ium bromide (13)
Compound 13 was synthesized by a similar procedure to 8a. The
dye was purified by precipitation from methanol with ether. This
compound was obtained in 41% yield; mp >260 ꢀC; 1H NMR
mp 223e225 ꢀC; 1H NMR (400 MHz, DMSO-d6):
d 1.65 (s, 6 H), 3.55
(s, 3 H), 3.94 (s, 3 H), 6.24 (d, J ¼ 12.8 Hz, 1 H), 6.78 (d, J ¼ 13.6 Hz, 1
H), 7.21 (t, J ¼ 7.6 Hz, 1 H), 7.34e7.42 (m, 2 H), 7.51 (t, J ¼ 7.6 Hz, 1 H),
7.58 (d, J ¼ 7.6 Hz, 1 H), 7.65 (t, J ¼ 7.6 Hz, 1 H), 7.87 (d, J ¼ 8.4 Hz, 1
H), 8.09 (d, J ¼ 8.0 Hz, 1 H), 8.40 (t, J ¼ 12.8 Hz, 1 H); 13C NMR
(400 MHz, DMSO-d6):
d
0.96 (t, J ¼ 7.2 Hz, 3 H), 1.44-1.49 (m, 2 H),
1.81e1.85 (m, 2 H), 3.92 (s, 3 H), 4.36 (t, J ¼ 7.2 Hz, 2 H), 7.19 (d,
J ¼ 13.2 Hz, 2 H), 7.70e7.73 (m, 4 H), 7.86 (d, J ¼ 7.2 Hz, 2 H), 8.04e
8.07 (m, 2 H), 8.34 (d, J ¼ 7.6 Hz, 2 H), 8.65 (d, J ¼ 7.2 Hz, 2 H), 9.16 (t,
(100 MHz, DMSO-d6):
d 28.71, 34.51, 48.73, 99.92, 102.82, 110.96,
114.92,122.72,123.69,124.54,125.80,126.46,128.78,128.87,140.65,
142.36, 143.40, 147.64, 168.17, 172.12. HRMS: Calcd for C22H23N2Sþ
m/z 347.1577, obsd m/z 347.1588.
J ¼ 13.2 Hz,1 H); 13C NMR (100 MHz, DMSO-d6):
d 0.59, 14.23, 20.14,
31.28, 31.85, 44.30, 55.40, 111.26, 111.40, 111.50, 111.67, 124.13,
124.19, 124.66, 129.48, 129.55, 129.80, 129.89, 130.11, 130.87, 130.92,
132.38, 141.22, 141.77, 148.51, 155.42, 156.17. HRMS: Calcd for
2.2.24. 2-((1E,3Z)-3-(3-Butylbenzo[d]oxazol-2(3H)-ylidene)prop-
1-en-1-yl)-1,3,3-trimethyl-3H-indol-1-ium iodide (9b)
C
30H27Nþ2 m/z 415.2169, obsd m/z 415.2172.
Compound 9b was synthesized by a similar procedure to 8a. The
dye was purified by chromatotron (2% methanol/dichloromethane).
This compound was obtained in 38% yield; mp 134 ꢀC; 1H NMR
2.3. Stock solutions
(400 MHz, DMSO-d6):
d
0.94 (t, J ¼ 7.2 Hz, 3 H), 1.37e1.44 (m, 2 H),
Stock solutions of the dyes and standard were prepared by
weighing the solid on a 5-digit analytical balance in an amber vial
and adding DMSO or 0.1 M NaOH solution via a class A volumetric
pipette. The vials were vortexed for 20 s and then sonicated for
5 min to ensure complete dissolution. The stock solutions were
stored in a dark freezer at 4 ꢀC when not in use.
1.66 (s, 6 H), 1.75e1.82 (m, 2 H), 3.54 (s, 3 H), 4.29 (t, J ¼ 7.6 Hz, 2 H),
6.23 (d, J ¼ 13.6 Hz,1 H), 6.41 (d, J ¼ 13.2 Hz,1 H), 7.21 (t, J ¼ 7.2 Hz,1
H), 7.34 (d, J ¼ 7.6 Hz, 2 H), 7.39 (t, J ¼ 7.6 Hz, 1 H), 7.47e7.58 (m, 3
H), 7.81 (d, J ¼ 8.0 Hz, 1 H), 7.87 (t, J ¼ 8.0 Hz, 1 H), 8.34 (t, J ¼ 13.2, 1
H); 13C NMR (100 MHz, DMSO-d6):
d 14.08, 19.83, 28.42, 30.21,